Research Article
Apelin-13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI-3K/Akt and MAPK/Erk Signaling Pathways
Table 1
Antibodies used in the present study.
| Antibody | Cat. number | Source | Manufacturer | Western dilution | Immunofluorescence dilution | HRMECs | Retina |
| Anti-actin | #4970S | rabbit | CST | 1 : 1000 | | | Anti-FAK | #3285S | rabbit | CST | 1 : 1000 | | | Anti-p-FAK | #8556S | rabbit | CST | 1 : 1000 | | | Anti-Src | #2108S | rabbit | CST | 1 : 1000 | | 1 : 100 | Anti-p-Src | #6943S | rabbit | CST | 1 : 1000 | | | Anti-PLCγ1 | #5690S | rabbit | CST | 1 : 1000 | | | Anti-p-PLCγ1 | #8713S | rabbit | CST | 1 : 1000 | | | Anti-p38 | #8690S | rabbit | CST | 1 : 1000 | | | Anti-p-p38 | #4511S | rabbit | CST | 1 : 1000 | | | Anti-p-Akt | #4060S | rabbit | CST | 1 : 1000 | | | Anti-Akt | #4691S | rabbit | CST | 1 : 1000 | | | Anti-VEGF | #9698S | rabbit | CST | 1 : 1000 | | | Anti-p-VEGF | #2748S | rabbit | CST | 1 : 1000 | | | Anti-VE-Cadherin | ab33168 | rabbit | Abcam | 1 : 1000 | | 1 : 200 | Anti-occludin | No. 331588 | mouse | Invitrogen | 1 : 1000 | 1 : 1000 | 1 : 1000 | Anti-ZO-1 | ab150266 | mouse | Abcam | 1 : 1000 | 1 : 1000 | 1 : 1000 | Anti-GAPDH | ab9484 | mouse | Abcam | 1 : 1000 | | | Anti-apelin-13 | ab59469 | rabbit | Abcam | 1 : 1000 | 1 : 500 | | Anti-APJ | ab84296 | Rabbit | Abcam | 1 : 1000 | | | HRP-conjugated goat anti-rabbit IgG | #7074S | — | CST | 1 : 5000 | | | FITC-conjugated donkey anti-rabbit-tetramethyl rhodamine isothiocyanate | ab6881 | | Abcam | | 1 : 1000 | 1 : 1000 | TRITC-conjugated donkey anti-rabbit-tetramethyl rhodamine isothiocyanate | ab6799 | | Abcam | 1 : 1000 | 1 : 1000 |
|
|
CST: cell signaling technology (Danvers, MA, USA); Abcam (Cambridge, MA, USA); Invitrogen (Carlsbad, CA, USA); FAK: focal adhesion kinase; Akt: protein kinase B; Erk: extracellular signal-regulated kinase;VE-Cadherin: vascular endothelial- (VE-) Cadherin; ZO-1: zonula occludens-1; PLC γ1: phospholipase C γ1; ; . |